sodium risedronate

Poland

Drugs containing this active substance

  • NORIFAZ

    The medicine is used for the treatment of osteoporosis in postmenopausal women to strengthen bones and reduce the risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    sodium risedronate 75 mg

    ATC: M05BA07

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used in the treatment of osteoporosis in postmenopausal women (to reduce the risk of vertebral and hip fractures) and in men with a high risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    sodium risedronate 35 mg

    ATC: M05BA07

    Manufacturer: Zentiva, joint-stock company

  • It is used in the treatment of osteoporosis in postmenopausal women and in men at particularly high risk of fractures. The medicine acts directly on the bones, making them stronger.

    Form: tablets, film-coated

    Active substance Dosage
    sodium risedronate 35 mg

    ATC: M05BA07

    Manufacturer: Adamed Pharma S.A. Pharmanel Pharmaceuticals S.A.